Current Status
Not Enrolled
Get Started

After the completion of this activity, the participant should be able to:

  1. Understand that PID is not rare in the geriatric age group and maybe difficult to diagnose and be able to define the aging population
  2. Understand that aging normally causes deterioration and lose of immune functions.
  3. Understand the demographic and geographic trends of aging population
  4. Understand the considerations of Ig therapy in regards to dosing, routes of administration, adverse reactions and other risks in geriatric patients
  5. Recognize the collaborative practice model to provide optimal patient care.

Roger H. Kobayashi, MD, MS
Ethan Huynh, PharmD, BCGP

ANCC 1 contact hour
ACPE 1 contact hour

1 IgCN® / IgCP® Recertification Units